Watch: Juul debuts first TV ad campaign
In the Make the Switch push, the company is using testimonials from people who say Juul e-cigarettes helped them quit smoking.
FDA
These 5 companies have the most at stake if drug prices are based on international averages
The Trump administration has proposed basing Medicare Part B drug prices on what other countries pay.
FDA turns attention to vapes in latest version of Real Cost anti-tobacco campaign
An estimated 10.7 million teens are vaping or thinking about it.
With a nod from the FDA, Teva enters white-hot migraine market
Teva’s Ajovy becomes the second approved CGRP migraine therapy, following Amgen’s Aimovig.
Five things for pharma marketers to know: Wednesday, September 12, 2018
FDA threatens to ban flavored vapes; Cigna launches $250 million venture fund; Takeda shutters Chicago operations.
Five things for pharma marketers to know: Friday, August 31, 2018
AstraZeneca’s lupus drug fails to meet goals; FDA expands investigation into heart drugs; Lilly names new head of Oncology.
FDA again reprimands Ascend Therapeutics for EstroGel promos that may mislead clinicians
Company draws its second untitled letter for material meant to plug the menopause brand to professionals.
Five things for pharma marketers to know: Friday, August 24, 2018
White House proposes rule for drug prices in DTC ads; FDA to study impact of side-effects warnings in drug ads; FDA approves Shire’s potential blockbuster HAE treatment.
First generic version of EpiPen approved by FDA
Teva’s generic EpiPen injector received a thumbs up from the FDA on Thursday.
Study: FDA anti-tobacco campaign prevented 350,000 teens from smoking
The study estimated the FDA’s anti-smoking campaign, The Real Cost, saved $31 billion in smoking-related costs to society.
